Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
QuintilesIMS
Baxter
Healthtrust
Merck
Argus Health
Express Scripts
Moodys
Harvard Business School

Generated: October 19, 2017

DrugPatentWatch Database Preview

Drug Master Files for: eptifibatide

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
9915AII10/21/1992CORDEN PHARMA BRUSSELS SAEPTIFIBATIDE (BULK)
14267AII7/6/1999ASPEN OSS BVEPTIFIBATIDE
18565AII8/1/2005LONZA AGEPTIFIBATIDE DRUG SUBSTANCE
21913AII8/28/2008TEVA PHARMACEUTICAL INDUSTRIES LTDEPTIFIBATIDE
23786AII4/30/2010ALP PHARM BEIJING CO LTDEPTIFIBATIDE
24864AII4/18/2011AMBIOPHARM INCEPTIFIBATIDE (NON-STERILE, BULK DRUG SUBSTANCE)
24933AII5/11/2011CHEMI SPAEPTIFIBATIDE
25092AII7/26/2011USV LTDEPTIFIBATIDE
26453AII9/20/2012HYBIO PHARMACEUTICAL CO LTDEPTIFIBATIDE ACETATE, NON-STERILE BULK DRUG SUBSTANCE
26457AII9/12/2012WUXI KAILI PHARMACEUTICAL CO LTDEPTIFIBATIDE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Johnson and Johnson
Fuji
AstraZeneca
Novartis
Boehringer Ingelheim
Merck
Covington
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot